Zhuzhou Qianjin Pharmaceutical Co., Ltd.

The company's predecessor was Zhuzhou Pharmaceutical Company's Proprietary Chinese Medicine Processing Plant, founded in 1966. It underwent a shareholding system reform in 1993 and listed on the Shanghai Stock Exchange in 2004. The company is mainly engaged in the development, production and sale of proprietary Chinese medicines, chemicals and feminine hygiene products, as well as the wholesale and retail business of pharmaceuticals. The company's leading products include gynecological Qianjin tablets (capsules), blood supplementation pills (granules), valsartan capsules, enalapril maleate tablets, difenidol hydrochloride tablets, silybin glucamine tablets, entecavir dispersible tablets, and a series of special gynecological wipes. Corporate honors: In 2005, the “Qianjin” brand was recognized as a well-known trademark in China, and the company won the title of “National Civilized Unit”; in 2018, Qianjin Pharmaceutical (brand “Qianjin”) was rated as a “Hunan Time-honored Brand”, and the company won the “National Enterprise Management Modernization Innovation Achievement Award”, “12th China Main Board Listed Company Top 100 Valuable Companies”, “National Intellectual Property Demonstration Enterprise”, and “National Equipment Management Excellent Unit”; in 2019, the company was awarded the “National Enterprise Technology Center” and “National Enterprise with Best Practice Enterprise in Corporate Culture” Leaderboard” No. 33; in 2020, the company was awarded the “National Green Factory”, and Jiang Duan, the chairman of the company, was pre-awarded the “National Outstanding Entrepreneur”. In 2021, the company won the title of “National Advanced Collective for Women's Merit” and other honors.